FFM
Fairmount Funds Management Portfolio holdings
AUM
$772M
This Quarter Return
-5.87%
1 Year Return
+35.05%
3 Year Return
+1,168.51%
5 Year Return
+1,432.11%
10 Year Return
–
AUM
$423M
AUM Growth
+$423M
(+39%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
32.75%
Top 10 Holdings %
Top 10 Hldgs %
74.09%
Holding
23
New
3
Increased
12
Reduced
–
Closed
1
Top Buys
| 1 |
Axsome Therapeutics
AXSM
|
$31.2M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$21.8M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$17.9M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$15.2M |
| 5 |
Insmed
INSM
|
$14.9M |
Top Sells
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$40.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Insmed
INSM
$28.8B
| $45.8M | 10.83% | 1,948,784 +635,177 | +48% | +$14.9M |
|
|
GBT
2
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $41M | 9.68% | 1,182,307 +439,307 | +59% | +$15.2M |
|
3
argenx
ARGX
$43.6B
| $39.2M | 9.26% | 124,244 +45,600 | +58% | +$14.4M |
|
|
4
Axsome Therapeutics
AXSM
$6.05B
| $39M | 9.22% | 942,571 +754,973 | +402% | +$31.2M |
|
5
Enanta Pharmaceuticals
ENTA
$180M
| $33.4M | 7.9% | 469,264 +81,864 | +21% | +$5.83M |
|
|
BHVN
6
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $28.4M | 6.71% | 239,314 +183,667 | +330% | +$21.8M |
|
|
7
Acadia Pharmaceuticals
ACAD
$4.38B
| $28M | 6.62% | 1,156,817 +740,000 | +178% | +$17.9M |
|
8
Keros Therapeutics
KROS
$618M
| $21.6M | 5.1% | 396,911 +104,078 | +36% | +$5.66M |
|
9
Nuvalent
NUVL
$5.52B
| $18.6M | 4.4% | 1,338,393 +423,779 | +46% | +$5.89M |
|
|
PNT
10
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $18.4M | 4.36% | 2,312,523 +793,141 | +52% | +$6.32M |
|
11
Viridian Therapeutics
VRDN
$1.5B
| $17.5M | 4.13% | 944,092 | – | – |
|
12
Tyra Biosciences
TYRA
$675M
| $13.7M | 3.25% | 1,284,990 +639,641 | +99% | +$6.84M |
|
|
AMRN
13
Amarin Corp
AMRN
$311M
| $13.6M | 3.22% | 4,133,237 +1,635,000 | +65% | +$5.38M |
|
14
Protagonist Therapeutics
PTGX
$3.67B
| $13M | 3.08% | +549,988 | New | +$13M |
|
15
Cogent Biosciences
COGT
$1.69B
| $11.7M | 2.76% | 1,558,975 | – | – |
|
16
Olema Pharmaceuticals
OLMA
$375M
| $11.4M | 2.69% | +2,669,300 | New | +$11.4M |
|
17
Instil Bio
TIL
$182M
| $7.24M | 1.71% | 673,905 | – | – |
|
18
Iovance Biotherapeutics
IOVA
$807M
| $6.49M | 1.53% | 389,588 | – | – |
|
19
Astria Therapeutics
ATXS
$349M
| $6.12M | 1.45% | 911,736 | – | – |
|
|
VRNA
20
Verona Pharma
VRNA
$9.16B
| $4.62M | 1.09% | 926,602 | – | – |
|
21
Annexon
ANNX
$226M
| $3.41M | 0.81% | +1,249,143 | New | +$3.41M |
|
|
ALLK
22
DELISTED
Allakos
ALLK
| $838K | 0.2% | 147,189 | – | – |
|
|
ZGNX
23
DELISTED
Zogenix, Inc.
ZGNX
| – | – | -2,502,259 | Closed | -$40.7M |
|